Search

everythinglearnresearchcommunity

for

Search:↓

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Skin issues can indicate immune system problems.

Transplant patients often get skin problems, with treatments varying by condition.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

MSF-VMDNet accurately segments skin cancer images better than existing methods.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Vaping may harm skin health by causing inflammation.